This webinar is an AAOS benefit: Attend for free!

Description

Meniscal tears are a very common clinical condition, often treated with surgery. While indications for meniscal repair are expanding, most meniscal tears are still treated with arthroscopic resection. Meniscal allograft transplantation (MAT) is an evolving treatment option for young, active patients with symptomatic meniscal-deficient knees. There is a growing body of evidence for good long-term outcomes from MAT, although the long-term chondroprotective potential is still unproven. This article reviews the latest evidence regarding the indications, surgical techniques, complications, rehabilitation, and reported outcomes after MAT.

Learning Objectives

• Review current indications for meniscal allograft transplantation (MAT) and identify appropriate patient selection criteria for young, active individuals with meniscal deficiency.
• Describe surgical techniques utilized in MAT, including key considerations that may impact graft success and patient outcomes.
• Evaluate reported clinical outcomes and potential complications associated with MAT, based on the latest evidence.
• Discuss postoperative rehabilitation strategies and the current understanding of long-term chondroprotective effects following meniscal transplantation.

Director

TBD

Faculty

Robert H. Brophy, MD, FAAOS, Derrick M Knapik, MD, FAAOS, Matthew V Smith, MD, FAAOS, Matthew J Matava, MD, FAAOS

The American Academy of Orthopaedic Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. The American Academy of Orthopaedic Surgeons designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Access to the recording will be granted for a duration of 2 years.